Menu
_8e29457b-accf-42c4-9828-22c455bc9297

CONTACTLESS IMAGING SYSTEM FOR RAPID VASCULAR ACCESS MONITORING

The vascular access is the lifeline that connects a dialysis patient to the dialysis machine. It must be kept clear for successful treatment. For this reason, the vascular access must undergo routine monitoring.

The vascular access is the lifeline that connects a dialysis patient to the dialysis machine. It must be kept clear for successful treatment. For this reason, the vascular access must undergo routine monitoring.

There are three major challenges to routine monitoring:

As dialysis clinics are VERY busy, it’s a challenge for the clinical team to consistently perform proper vascular access monitoring.

There are no standard objective measurements for monitoring, meaning results are completely subjective and variable.

The current physical examination by nurses can be burdensome and require specialized training.

The PatenSee System addresses these challenges with its contactless, optical, fistula monitoring system.

PatenSee’s System

PatenSee’s system standardizes and digitizes the ‘look, listen, feel’ physical examination of the patient’s vascular access site through a rapid (1-2 minute) non-contact imaging technology combined with AI, designed as a clinical support tool to enable early prediction of stenosis and other complications.

Learn More…

How It Works in a Hemodialysis Clinic

Patient arrives for a dialysis treatment (every 2-3 days).
Patient arrives for a dialysis treatment (every 2-3 days).
x60sec PatenSee imaging (weekly), seamlessly integrated into dialysis clinic patient workflow.
x60sec PatenSee imaging (weekly), seamlessly integrated into dialysis clinic patient workflow.
Simple, real-time data collection and analysis.
Simple, real-time data collection and analysis.
Standardized clinical support tool.
Standardized clinical support tool.

Contact Us

Info

+972-72-251-3566
Please use form

Address

8 Ariel Sharon St.
Or Yehuda, 6037606. Israel

407 E. Fort Street
Suite 205
Detroit, MI 48226,

Name *
Email *
Subject *
Message

Patensee is limited to investigational use only and is not approved by FDA for sale in the United States

Back To Top
© Patensee 2025
Powered by: SPInc

PatenSee is a clinical-stage medical device company developing a non-contact monitoring system for the early detection of vascular access stenosis in hemodialysis patients. Using advanced, multi-modal imaging technologies, AI and machine learning, PatenSee’s device alerts caregivers of vascular access stenosis risk at the earliest stage, enabling timely interventions to protect the patient’s hemodialysis lifeline, improve the quality of care and prolong the life of the fistula. 


PatenSee is a portfolio company of MEDX Xelerator, a medical device incubator backed by Boston Scientific, Sheba Medical Center, MEDX Ventures Group, Consensus Business Group (CBG), West Pharmaceuticals and The Portland Trust.